{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T12:09:31Z","timestamp":1783944571127,"version":"3.55.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2002,1,1]],"date-time":"2002-01-01T00:00:00Z","timestamp":1009843200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2002,1,1]],"date-time":"2002-01-01T00:00:00Z","timestamp":1009843200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hum Hypertens"],"published-print":{"date-parts":[[2002,1,1]]},"DOI":"10.1038\/sj.jhh.1001298","type":"journal-article","created":{"date-parts":[[2002,9,5]],"date-time":"2002-09-05T18:38:32Z","timestamp":1031251112000},"page":"5-11","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":89,"title":["Sibutramine is safe and effective for weight loss in obese patients whose hypertension is well controlled with angiotensin-converting enzyme inhibitors"],"prefix":"10.1038","volume":"16","author":[{"given":"F G","family":"McMahon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S P","family":"Weinstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Rowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K R","family":"Ernst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Fujioka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"The Sibutramine in Hypertensives Clinical Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2002,3,1]]},"reference":[{"key":"BF1001298_CR1","doi-asserted-by":"publisher","first-page":"3248","DOI":"10.1161\/01.CIR.96.9.3248","volume":"96","author":"RH Eckel","year":"1997","unstructured":"Eckel RH and for the Nutrition Committee. Obesity and heart disease. A statement for healthcare professionals from the Nutrition Committee, American Heart Association Circulation 1997 96: 3248\u20133250","journal-title":"Circulation"},{"key":"BF1001298_CR2","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1093\/oxfordjournals.aje.a117385","volume":"141","author":"EB Rimm","year":"1995","unstructured":"Rimm EB et al. Body size and fat distribution as predictors of coronary heart disease among middle-aged and older US men Am J Epidemiol 1995 141: 1117\u20131127","journal-title":"Am J Epidemiol"},{"key":"BF1001298_CR3","doi-asserted-by":"publisher","first-page":"983","DOI":"10.7326\/0003-4819-103-6-983","volume":"103","author":"TB Van Itallie","year":"1985","unstructured":"Van Itallie TB . Health implications of overweight and obesity in the United States Ann Intern Med 1985 103: 983\u2013988","journal-title":"Ann Intern Med"},{"key":"BF1001298_CR4","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1056\/NEJM199910073411501","volume":"341","author":"EE Calle","year":"1999","unstructured":"Calle EE et al. Body-mass index and mortality in a prospective cohort of U.S. adults N Engl J Med 1999 341: 1097\u20131105","journal-title":"N Engl J Med"},{"key":"BF1001298_CR5","doi-asserted-by":"crossref","unstructured":"Expert Panel on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults. Executive summary of the clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults Arch Intern Med 1998 158: 1855\u20131867","DOI":"10.1001\/archinte.158.17.1855"},{"key":"BF1001298_CR6","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1002\/j.1550-8528.1999.tb00701.x","volume":"7","author":"GA Bray","year":"1999","unstructured":"Bray GA et al. Sibutramine produces dose-related weight loss Obes Res 1999 7: 189\u2013198","journal-title":"Obes Res"},{"key":"BF1001298_CR7","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1016\/S0140-6736(00)03491-7","volume":"356","author":"WPT James","year":"2000","unstructured":"James WPT et al. Effect of sibutramine on weight maintenance after weight loss: a randomised trial Lancet 2000 356: 2119\u20132125","journal-title":"Lancet"},{"key":"BF1001298_CR8","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1093\/ajcn\/68.6.1180","volume":"68","author":"DL Hansen","year":"1998","unstructured":"Hansen DL et al. Thermogenic effects of sibutramine in humans Am J Clin Nutr 1998 68: 1180\u20131186","journal-title":"Am J Clin Nutr"},{"key":"BF1001298_CR9","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1161\/01.CIR.97.21.2099","volume":"97","author":"RH Eckel","year":"1998","unstructured":"Eckel RH, Krauss RM for the AHA Nutrition Committee. American Heart Association call to action: obesity as a major risk factor for coronary heart disease Circulation 1998 97: 2099\u20132100","journal-title":"Circulation"},{"key":"BF1001298_CR10","first-page":"397","volume":"16","author":"DJ Goldstein","year":"1992","unstructured":"Goldstein DJ . Beneficial health effects of modest weight loss Int J Obes Relat Metab Disord 1992 16: 397\u2013415","journal-title":"Int J Obes Relat Metab Disord"},{"key":"BF1001298_CR11","doi-asserted-by":"crossref","unstructured":"Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure Arch Intern Med 1997 157: 2413\u20132446","DOI":"10.1001\/archinte.157.21.2413"},{"key":"BF1001298_CR12","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1345\/aph.18319","volume":"33","author":"CA Luque","year":"1999","unstructured":"Luque CA, Rey JA . Sibutramine: a serotonin-norepinephrine reuptake-inhibitor for the treatment ofobesity Ann Pharmacother 1999 33: 968\u2013978","journal-title":"Ann Pharmacother"},{"key":"BF1001298_CR13","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/S0002-9343(98)00411-2","volume":"106","author":"M Apfelbaum","year":"1999","unstructured":"Apfelbaum M et al. Long-term maintenance of weight loss after a very-low-calorie diet: a randomized blinded trial of the efficacy and tolerability of sibutramine Am J Med 1999 106: 179\u2013184","journal-title":"Am J Med"},{"key":"BF1001298_CR14","first-page":"S9","volume":"17 (Suppl 1)","author":"L Hansson","year":"1999","unstructured":"Hansson L . The Hypertension Optimal Treatment study and the importance of lowering blood pressure J Hypertens 1999 17 (Suppl 1): S9\u2013S13","journal-title":"J Hypertens"},{"key":"BF1001298_CR15","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1016\/S0140-6736(98)04311-6","volume":"351","author":"L Hansson","year":"1998","unstructured":"Hansson L et al. Effects of intensive blood-pressure lowering and low-dose aspirin inpatients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial Lancet 1998 351: 1755\u20131762","journal-title":"Lancet"},{"key":"BF1001298_CR16","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/sj.ijo.0801128","volume":"24","author":"N Finer","year":"2000","unstructured":"Finer N et al. One-year treatment of obesity: a randomized, double-blind, placebo-controlled, multicentre study of orlistat, a gastrointestinal lipase inhibitor Int J Obes 2000 24: 306\u2013313","journal-title":"Int J Obes"},{"key":"BF1001298_CR17","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1046\/j.1463-1326.2000.00081.x","volume":"2","author":"K Fujioka","year":"2000","unstructured":"Fujioka K et al. Weight loss with sibutramine improves glycaemic control and other metabolic parameters in obesepatients with type 2 diabetes mellitus Diabetes Obes Metab 2000 2: 175\u2013187","journal-title":"Diabetes Obes Metab"},{"key":"BF1001298_CR18","first-page":"88S","volume":"8 (Suppl 1)","author":"K Lauterbach","year":"2000","unstructured":"Lauterbach K, Evers T . Framingham analysis: coronary heart disease risk reduction with weight loss in obesity on sibutramine treatment. [abstract PB 83] Obes Res 2000 8 (Suppl 1): 88S","journal-title":"Obes Res"},{"key":"BF1001298_CR19","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.1001\/archinte.160.14.2185","volume":"160","author":"FG McMahon","year":"2000","unstructured":"McMahon FG et al. Efficacy and safety of sibutramine in obese white and African Americanpatients with hypertension: a 1-year, double-blind, placebo-controlled, multicenter trial Arch Intern Med 2000 160: 2185\u20132191","journal-title":"Arch Intern Med"}],"container-title":["Journal of Human Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/1001298.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1001298","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1001298.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,17]],"date-time":"2022-03-17T14:28:01Z","timestamp":1647527281000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1001298"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,1,1]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2002,1,1]]}},"alternative-id":["BF1001298"],"URL":"https:\/\/doi.org\/10.1038\/sj.jhh.1001298","relation":{},"ISSN":["0950-9240","1476-5527"],"issn-type":[{"value":"0950-9240","type":"print"},{"value":"1476-5527","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,1,1]]},"assertion":[{"value":"1 March 2002","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}